✦ LIBER ✦

A phase II trial of Topotecan (Hycamtin®) with Ifosfamide (Duvaxan®) plus Mesna (Mesnex®) as first line treatment in patients (pts) with small cell lung cancer (SCLC). A preliminary report

✍ Scribed by Ventriglia, M; Cabrera, L; Maidana, M; Vigo, S; Cilurzo, M; Estévez, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-766 Phase II study of topotecan (T) an

✍ Hainsworth, J.; Palmer, M.; Granick, J.; Boston, B.; Bonomi, P.; Althouse, D.; D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Single agent oral topotecan (OT) as firs

✍ Eckardt, J.R; Palmer, M.C; Fanucchi, M.P; Gralla, R; Martins, H; Poulin, R; Fiel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A phase II study of paclitaxel (P) and c

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

A phase II trial of weekly chemotherapy

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

A Phase II Trial of Erlotinib As Front-L

✍ Athanasios G. Pallis; Alexandra Voutsina; Nikolaos Kentepozidis; Stylianos Giass 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 374 KB

Carboplatin plus gemcitabine as first-li

✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Kentepozidis, N.; Polyzos, A.; Kotsa 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 48 KB